Atopic Dermatitis

72% of AD patients report poor mental health symptoms for one to 10 days in the previous month

A survey from the National Eczema Association in the U.S. has revealed that patients with AD tend to experience poor mental health symptoms.

VIDEO: Patch tests for allergic contact dermatitis still effective in AD patients on dupilumab

The use of dupilumab in patients with AD did not significantly affect the results of patch tests for allergic contact dermatitis.

New bacteriophages identified in skin microbiome

A research study from Vienna has reported that bacteriophages found in the skin microbiome of patients with AD may lead to the...

Barriers to care for U.S. sexual and gender minority patients with inflammatory skin disease

Findings from a cross-sectional study of survey data suggest that U.S. sexual and gender minority (SGM) patients with chronic...

VIDEO: Colloidal oatmeal as efficacious as barrier cream in Black children with AD

Colloidal oatmeal 1% is efficacious in treating mild-to-moderate AD in Black children, according to a recent study.

EADV 2023 Day 2 Evening: Molecular Signature of Chronic Hand Eczema

Dr. Vimal Prajapati reports on common molecular signatures of chronic hand eczema at the 2023 EADV Congress in Berlin.

EADV 2023 Day 2 Afternoon: Treating Severe Atopic Dermatitis with Tapinarof 1% Cream

Dr. Vimal Prajapati reports about tapinarof 1% cream for treating severe AD at the 2023 EADV Congress in Berlin.

EADV 2023 Day 1 Evening: Late Breakers in Atopic Dermatitis

Dr. Mark Kirchhof reports late breakers presentations around atopic dermatitis and prurigo nodularis from the 2023 EADV Congress in Berlin.

1

it's where dermatology lives